Similar articles for PMID: 25726555

Year	Number of Results
2005	1
2006	1
2007	2
2008	3
2009	1
2010	4
2011	3
2012	1
2013	3
2014	5
2015	15
2016	6
2017	17
2018	10
2019	4
2020	14
2021	9
2022	5
2023	4
2024	0

1

Diagnosing α1-antitrypsin deficiency: how to improve the current algorithm.

McElvaney NG. McElvaney NG. Eur Respir Rev. 2015 Mar;24(135):52-7. doi: 10.1183/09059180.10010814. Eur Respir Rev. 2015. PMID: 25726555 Free PMC article. Review.

2

Advances in managing COPD related to α₁ -antitrypsin deficiency: An under-recognized genetic disorder.

Craig TJ, Henao MP. Craig TJ, et al. Allergy. 2018 Nov;73(11):2110-2121. doi: 10.1111/all.13558. Epub 2018 Jul 26. Allergy. 2018. PMID: 29984428 Free PMC article. Review.

3

The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.

Lascano JE, Campos MA. Lascano JE, et al. Postgrad Med. 2017 Nov;129(8):889-895. doi: 10.1080/00325481.2017.1381539. Epub 2017 Oct 5. Postgrad Med. 2017. PMID: 28929906 Review.

4

The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.

Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J. Sandhaus RA, et al. Chronic Obstr Pulm Dis. 2016 Jun 6;3(3):668-682. doi: 10.15326/jcopdf.3.3.2015.0182. Chronic Obstr Pulm Dis. 2016. PMID: 28848891 Free PMC article. Review.

5

European screening for alpha₁ -antitrypsin deficiency in subjects with lung disease.

Greulich T, Averyanov A, Borsa L, Rozborilová E, Vaicius D, Major T, Chopyak V, Tudorache V, Konstantinova T, Camprubí S. Greulich T, et al. Clin Respir J. 2017 Jan;11(1):90-97. doi: 10.1111/crj.12310. Epub 2015 Jun 11. Clin Respir J. 2017. PMID: 25919395

6

α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.

Campos MA, Lascano J. Campos MA, et al. Ther Adv Respir Dis. 2014 Oct;8(5):150-61. doi: 10.1177/1753465814542243. Epub 2014 Jul 9. Ther Adv Respir Dis. 2014. PMID: 25013223 Free article. Review.

7

SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.

Sorrells S, Camprubi S, Griffin R, Chen J, Ayguasanosa J. Sorrells S, et al. Respir Med. 2015 Apr;109(4):490-9. doi: 10.1016/j.rmed.2015.01.022. Epub 2015 Feb 13. Respir Med. 2015. PMID: 25727857 Free article. Clinical Trial.

8

Pathophysiology of Alpha-1 Antitrypsin Lung Disease.

Kalfopoulos M, Wetmore K, ElMallah MK. Kalfopoulos M, et al. Methods Mol Biol. 2017;1639:9-19. doi: 10.1007/978-1-4939-7163-3_2. Methods Mol Biol. 2017. PMID: 28752442 Review.

9

Recent advances in understanding and treating COPD related to α₁-antitrypsin deficiency.

Henao MP, Craig TJ. Henao MP, et al. Expert Rev Respir Med. 2016 Dec;10(12):1281-1294. doi: 10.1080/17476348.2016.1249851. Epub 2016 Nov 4. Expert Rev Respir Med. 2016. PMID: 27771979 Review.

10

Trends of testing for and diagnosis of α₁-antitrypsin deficiency in the UK: more testing is needed.

Soriano JB, Lucas SJ, Jones R, Miravitlles M, Carter V, Small I, Price D, Mahadeva R; Respiratory Effectiveness Group. Soriano JB, et al. Eur Respir J. 2018 Jul 4;52(1):1800360. doi: 10.1183/13993003.00360-2018. Print 2018 Jul. Eur Respir J. 2018. PMID: 29853490 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year